Asston Pharmaceuticals shares make weak debut, lists at ₹119, down 3.25% from IPO price

Asston Pharmaceuticals debuted at ₹119 on BSE SME on July 16, down 3.25% from its IPO price of ₹123. The IPO raised ₹27.63 crore, attracting 186.55 times subscription, with retail investors at 172.06 times and QIBs at 85.76 times.

Markets